The tablets are a potent diuretic intended for the treatment of edema.
The new treatment represents the first approved generic form of brand-name Edecrin tablets, which are produced by Canada-based Valeant Pharmaceuticals.
Edenbridge Pharmaceuticals, headquartered in Parsippany, N.J., plans to launch the ethacrynic acid tablets as soon as possible.
More articles on the drug market:
Sanofi, U.S. Army partner to speed up Zika vaccine development
Drugmakers hesitant to let generic rival Teva join PhRMA
Viewpoint: How drug coupons keep prices high
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.